# matrihealth

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/matrihealth

- Industry: Biotechnology
- Headquarters: Halle, Germany
- Website: www.matrihealth.com/home/
- Latest round: Seed (Jun 3, 2024)
- Investors on record: 1

## About

Based in Halle, Germany, and founded in 2022 by co-founders Tobias Hedtke, Marco Götze, Dirk Schuster, and Christian Schmelzer, Matrihealth GmbH provides elastin and elastin-based products for research and development, cosmetics, food, and medical applications. In June 2024, MatriHealth GmbH raised seed funding from investor Fraunhofer Venture.

Matrihealth GmbH's product portfolio includes elastin-based solutions designed for research, bioprinting, medical applications, cosmetics, and food supplements. The elastin offered for research and development includes both soluble and non-soluble forms, enabling researchers to explore biomaterial development and tissue engineering. In the field of bioprinting, Matrihealth provides elastin-based biomaterial inks that are used in tissue engineering applications. These inks are formulated for use with 3D bioprinting technologies, supporting advancements in tissue modelling and regenerative medicine.


The company will use the June 2024 funding to scale its production capacities and tap into market segments.

## Funding rounds

- Seed, Jun 3, 2024 — Fraunhofer Venture

## Investors

- Fraunhofer Venture (https://capitalatlas.ai/funds/fraunhofer-venture) — Seed